Why Some Patients Return to Older GLP-1 Drugs After Trying Ozempic or Mounjaro

Some patients who switch to Ozempic or Mounjaro eventually return to older GLP-1 drugs like Byetta. Side effects, familiarity, insurance coverage, and treatment routines all influence long-term diabetes medication adherence.

Why Some Patients Quit Byetta After Switching to Weekly GLP-1 Drugs Like Ozempic or Mounjaro

Many patients who once relied on Byetta have transitioned to weekly GLP-1 drugs like Ozempic and Mounjaro. The shift reflects more than convenience — it highlights how injection burden, meal timing, travel logistics, and adherence shape modern diabetes care.